mazindol has been researched along with Hyperlipemia in 3 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate, in compliant patients, the pharmaceutical costs of treating obesity with fenfluramine/mazindol, fenfluramine/phentermine, caffeine/ephedrine, or mazindol relative to the pharmaceutical costs of treating obesity-related comorbid conditions and reducing cardiovascular risk." | 3.70 | Pharmaceutical cost savings of treating obesity with weight loss medications. ( Bray, GA; Greenway, FL; Rood, JC; Ryan, DH; Smith, SR; Tucker, EW, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greenway, FL | 1 |
| Ryan, DH | 1 |
| Bray, GA | 1 |
| Rood, JC | 1 |
| Tucker, EW | 1 |
| Smith, SR | 1 |
| Ueno, M | 1 |
| Zdichynec, B | 1 |
| Rechmani, BA | 1 |
1 review available for mazindol and Hyperlipemia
| Article | Year |
|---|---|
[Hyperlipidemia with obesity].
Topics: Body Mass Index; Coronary Disease; Diagnosis, Differential; Diet, Fat-Restricted; Diet, Reducing; Ex | 2001 |
1 trial available for mazindol and Hyperlipemia
| Article | Year |
|---|---|
[Modification of serum lipid values and of the neurovegetative equilibrium in subjects under mazindol therapy].
Topics: Adult; Autonomic Nervous System; Clinical Trials as Topic; Female; Humans; Hyperlipidemias; Indoles; | 1979 |
1 other study available for mazindol and Hyperlipemia
| Article | Year |
|---|---|
Pharmaceutical cost savings of treating obesity with weight loss medications.
Topics: Adolescent; Adult; Appetite Depressants; Caffeine; Cardiovascular Diseases; Diabetes Mellitus; Drug | 1999 |